Provenge, Its Future & A Clinical Trail Alternative for Men with Hormone Dependent Prostate Cancer

I have received a number of e-mails from men who are both frustrated that Provenge is not yet approved and who are frustrated that even when approved they will not qualify to get the treatment. I understand the frustration and feel the same way. The first question is will the FDA approve Provenge? Only time [...]

Watch the DOD Funding For Prostate Cancer Continue To Shrink

I just heard the shocking, but not really surprising news that only 28 members of the House of Representatives have signed onto the appropriations request letter this year for the funding of the Department of Defense Congressionally Directed Medical Research Program for Prostate Cancer. […]

Clinical Trials That Exclude Gay and Lesbian Patients

Clinical Trials That Exclude Gay and Lesbian Patients By Darryl (published on Malecare’s blog at: prostatecancerblog.org The March 18, 2010 issue of *New England Journal of Medicine* (Volume 362, #11, March 18) includes a study: “Clinical Trials That Explicitly Exclude Gay and Lesbian Patients.” […]

Prostate Cancer Diagnosis and Treatment — Good Medicine or Business as Usual?

This is a follow-up to a post I wrote called, "PSA Testing: The Good, the Bad and the Ugly".   http://prostatecancerblog.net/wp-admin/post.php?action=edit&post=2120.  Please read that before you read this. Dr. Richard Ablin, father of the PSA test, argued in a New York Times op-ed piece recently that the widespread, routine use of the test to screen for prostate cancer [...]

By |2021-07-19T10:59:52-04:00March 31st, 2010|Postings|21 Comments
Go to Top